Search - tctmd.com

Displaying 241 - 260 of 300

Sort: Relevancy | Date

Presentation ACC 2012

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Presenter: Gennaro Sardella

March 24, 2012

News Conference News ACC 2012

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Jason Kahn

March 24, 2012

News Daily News

Better Clopidogrel Response Seen with Increased Smoking Levels

Jason Kahn

March 21, 2012

News Daily News

Anemia Inhibits Platelet Response to Clopidogrel in PCI Patients

March 21, 2012

News Daily News

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

Yael L. Maxwell

March 15, 2012

News Daily News

TCTMD’s Top 10 Most Popular News Stories From 2011

Jason Kahn

March 08, 2012

News Daily News

Study Focuses on Systemic Inflammation After TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Estudio se Centra en la Inflamación Sistémica tras la TAVR

Caitlin E. Cox

March 07, 2012

News Daily News

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

January 16, 2012

News Daily News

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

L.A. McKeown

January 12, 2012

Presentation TCT 2012

<b>Pharmacodynamic Effect of Double-dose Clopidogrel versus Adding Dipyridamole In Patients With High On-treatment Platelet Reactivity (ACCEL-DIP) study</b>

Presenter: Yongwhi Park, Young-Hoon Jeong, Jeong-Rang Park, Seok-Jae Hwang, Choong Hwan Kwak, Jin-Yong Hwang

January 03, 2012

Presentation TCT 2012

Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel

Presenter: Jean-Pierre P. Dery, Abdelouahed Khalil, Ugo D?ry, M?lanie Roy, Pierluigi Tricoci, Richard Becker, Stéphane Rinfret, Éric Larose, G?rald Barbeau, Robert DeLarochelli?re, Josep Rod?s-Cabau, Olivier F. Bertrand

January 03, 2012

News Daily News

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

January 03, 2012

Presentation TCT 2012

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

Presenter: Andr?s Kom?csi, Orsolya Rideg, Gy?ngyv?r K?lt?, Andr?s Vorobcsuk, Daniel Aradi

January 03, 2012

News Daily News

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

December 04, 2011

News Conference News

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

November 22, 2011

News Conference News

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

November 21, 2011

News Conference News

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

November 21, 2011

Advertisement

RESET Study: Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel

Prasugrel Effective in Stable Patients With Poor Response to Clopidogrel

Better Clopidogrel Response Seen with Increased Smoking Levels

Anemia Inhibits Platelet Response to Clopidogrel in PCI Patients

TARGET-CABG Published: Waiting Period to CABG Flexible Per Platelet Function Test

TCTMD’s Top 10 Most Popular News Stories From 2011

Study Focuses on Systemic Inflammation After TAVR

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Estudio se Centra en la Inflamación Sistémica tras la TAVR

BRIDGE Published: Cangrelor Promising Option as Bridging Therapy

Silent Cerebral Infarcts After Angiography Linked to Insufficient Platelet Inhibition

<b>Pharmacodynamic Effect of Double-dose Clopidogrel versus Adding Dipyridamole In Patients With High On-treatment Platelet Reactivity (ACCEL-DIP) study</b>

Paraoxonase-1 (PON1) Activity And PON1 Polymorphisms Have No Effect On Platelet Reactivity In Patients Treated With Clopidogrel

Meta-analysis: Data Do Not Support Genotyping for Clopidogrel Response

Genetic Variants Affecting Clopidogrel Metabolism Have Minor Influence on Platelet Reactivity After Elective Percutaneous Coronary Intervention

Elevated CRP—But Not High Platelet Reactivity—Predictive After DES

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

Stent Thrombosis Linked to Uncovered, Malapposed Stent Struts

SPICE: Esomeprazole Reduces Antiplatelet Effect of Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content